Earnings History Data for Ligand Pharmaceuticals Incorporated (LGND) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2024 PM LGND Ligand Pharmaceuticals Incorporated 1,320 0.79 0.24 -0.26 Ligand Pharmaceuticals Non-GAAP EPS of $1.05 beats by $0.39, revenue of $28.1M beats by $2.46M
[2/27/2024 7:33 AM]
88.44 14.02 
(18.84%)
85.01 10.59 
(14.23%)
49.24 - 94.57 705,899 110,000 15,159
08-11-2023 AH LGND Ligand Pharmaceuticals Incorporated 923.47 0.71 0.36 -0.20 Ligand Pharmaceuticals Non-GAAP EPS of $1.02 beats by $0.40, revenue of $32.87M beats by $5.65M
[11/8/2023 4:43 PM]
54.62 2.40 
(4.59%)
52.23 0.0 
(0.00%)
49.24 - 85.70 233,298 90,000 2,299
08-08-2023 AH LGND Ligand Pharmaceuticals Incorporated 1,150 1.10 0.39 -0.14 Ligand Pharmaceuticals Non-GAAP EPS of $1.42 beats by $0.76, revenue of $26.4M beats by $0.67M
[8/8/2023 5:42 PM]
70.67 3.55 
(5.28%)
66.74 -0.39 
(-0.58%)
47.76 - 85.70 144,679 80,000 2,534
04-05-2023 AH 4:00 PM ET
(May 4)
LGND Ligand Pharmaceuticals Incorporated 1,280 1.96 0.57 0.15 Ligand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39, revenue of $43.9M beats by $10.35M
[5/4/2023 5:01 PM]
79.47 2.77 
(3.60%)
76.71 0.0 
(0.00%)
45.25 - 85.70 139,243 90,000 3,371
22-02-2023 AH 4:00 PM ET
(Feb 22)
LGND Ligand Pharmaceuticals Incorporated 1,930 -0.26 0.71 1.34 Ligand Pharmaceuticals Non-GAAP EPS of $1.36 beats by $0.24, revenue of $50.38M beats by $10.75M
[2/22/2023 4:03 PM]
75.09 2.97 
(4.12%)
72.12 0.0 
(0.00%)
45.25 - 83.95 137,674 120,000 6,112
07-11-2022 AH 4:00 PM ET
(Nov 7)
LGND Ligand Pharmaceuticals Incorporated 1,060 -0.20 0.09 1.18 Ligand Pharmaceuticals Non-GAAP EPS of $0.41 misses by $0.02, revenue of $66.09M beats by $27.76M
[11/7/2022 4:25 PM]
69.81 6.97 
(11.08%)
62.84 0.0 
(0.00%)
45.25 - 105.99 254,282 230,000 5,168
08-08-2022 AH 4:00 PM ET
(Aug 8)
LGND Ligand Pharmaceuticals Incorporated 1,540 -0.14 0.12 1.16 Ligand Pharmaceuticals Non-GAAP EPS of $1.03 beats by $0.60, revenue of $57.4M beats by $19.67M
[8/8/2022 4:34 PM]
102.34 3.09 
(3.11%)
99.25 0.0 
(0.00%)
72.57 - 169.98 77,989 90,000 5,380
04-05-2022 AH 4:00 PM ET
(May 4)
LGND Ligand Pharmaceuticals 1,566 0.15 0.61 0.00 Ligand Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.10, revenue of $45.69M beats by $11.48M
[5/4/2022 4:52 PM]
90.28 -5.72 
(-5.96%)
96.00 0.0 
(0.00%)
88.11 - 169.98 268,991 160,000 1,073
17-02-2022 AH 4:00 PM ET
(Feb 17)
LGND Ligand Pharmaceuticals Incorporated 2,010 1.34 0.97 1.20 Ligand Pharmaceuticals Non-GAAP EPS of $1.80 beats by $0.43, revenue of $72.5M beats by $7.41M
[2/17/2022 4:04 PM]
103.32 -8.89 
(-7.92%)
111.00 -1.21 
(-1.08%)
99.01 - 172.19 405,704 130,000 3,813
09-11-2021 AH 4:00 PM ET
(Nov 9)
LGND Ligand Pharmaceuticals Incorporated 2,630 1.18 0.61 0.71 Ligand Pharmaceuticals EPS beats by $0.54, beats on revenue
[11/9/2021 4:04 PM]
165.88 14.00 
(9.22%)
160.50 8.62 
(5.68%)
79.52 - 219.75 308,139 130,000 1,413
29-07-2021 AH 4:00 PM ET
(Jul 29)
LGND Ligand Pharmaceuticals Incorporated 2,030 1.16 1.15 0.65 Ligand Pharmaceuticals EPS beats by $0.27, beats on revenue; updates full year guidance
[7/29/2021 4:06 PM]
113.71 -5.25 
(-4.41%)
118.96 0.0 
(0.00%)
78.26 - 219.75 120,614 130,000 22,166
03-05-2021 AH 4:00 PM ET
(May 3)
LGND Ligand Pharmaceuticals Incorporated 2,430 1.03 0.72 0.62 Ligand Pharmaceuticals EPS beats by $0.28, misses on revenue
[5/3/2021 4:03 PM]
132.03 -13.20 
(-9.09%)
138.00 -7.23 
(-4.98%)
78.26 - 219.75 280,906 100,000 1,488
03-02-2021 PM 8:00 AM ET
(Feb 3)
LGND Ligand Pharmaceuticals Incorporated 2,980 1.20 0.77 0.42 Ligand Pharmaceuticals EPS beats by $0.63, beats on revenue
[2/3/2021 7:42 AM]
177.74 0.66 
(0.37%)
185.50 8.42 
(4.75%)
57.24 - 198.79 812,444 1,774,721 4,110
30-10-2020 PM 7:30 AM ET
(Oct 30)
LGND Ligand Pharmaceuticals Incorporated 1,390 0.71 0.81 0.15 Ligand Pharmaceuticals EPS beats by $0.06, misses on revenue
[10/30/2020 8:08 AM]
82.63 -0.44 
(-0.53%)
83.08 0.01 
(0.01%)
57.24 - 127.80 493,830 557,156 264
03-08-2020 PM 8:00 AM ET
(Aug 3)
LGND Ligand Pharmaceuticals Incorporated 2,030 0.65 0.39 0.41 Ligand Pharmaceuticals beats on revenue
[8/3/2020 7:31 AM]
117.25 0.07 
(0.06%)
120.00 2.82 
(2.41%)
57.24 - 127.80 348,973 219,586 14,985
06-05-2020 AH LGND Ligand Pharmaceuticals Incorporated 1,540 0.62 0.32 0.97 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0